Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1524 |
Nilotinib
尼洛替尼,尼罗替尼,Tasigna,AMN107 |
Bcr-Abl; Autophagy | Angiogenesis; Autophagy; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Nilotinib (AMN107) 是一种 Bcr-Abl 酪氨酸激酶抑制剂,具有抗肿瘤活性。 | |||
T71068 |
Nilotinib dihydrochloride dihydrate
|
||
Nilotinib dihydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. | |||
T68338 | Nilotinib hydrochloride dihydrate | ||
Nilotinib hydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. | |||
T12224 |
Nilotinib-d6
AMN107 D6 |
Others | Others |
Nilotinib D6 is a deuterium labeled Nilotinib which is an orally available inhibitor of Bcr-Abl tyrosine kinase ,and with antineoplastic activity. |